200 related articles for article (PubMed ID: 36350016)
1. Neurodevelopmental outcome after antenatal therapy for fetal supraventricular tachyarrhythmia: 3-year follow-up of multicenter trial.
Miyoshi T; Maeno Y; Matsuda T; Ito Y; Inamura N; Kim KS; Shiraishi I; Kurosaki K; Ikeda T; Sago H; ;
Ultrasound Obstet Gynecol; 2023 Jan; 61(1):49-58. PubMed ID: 36350016
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diagnosis and management of fetal supraventricular tachyarrhythmia and postnatal outcomes.
Demirci O; Tosun Ö; Bolat G
J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102323. PubMed ID: 35063720
[TBL] [Abstract][Full Text] [Related]
3. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
Pete B; Hajdú J; Papp Z
Orv Hetil; 2004 Dec; 145(52):2611-7. PubMed ID: 15724696
[TBL] [Abstract][Full Text] [Related]
5. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
Tunca Sahin G; Beattie RB; Uzun O
Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
[TBL] [Abstract][Full Text] [Related]
6. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops.
Oudijk MA; Gooskens RH; Stoutenbeek P; De Vries LS; Visser GH; Meijboom EJ
Ultrasound Obstet Gynecol; 2004 Aug; 24(2):154-8. PubMed ID: 15287052
[TBL] [Abstract][Full Text] [Related]
7. Antenatal antiarrhythmic treatment for fetal tachyarrhythmias: a study protocol for a prospective multicentre trial.
Miyoshi T; Maeno Y; Sago H; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Shozu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Ikeda T; Yamamoto H; Hamasaki T;
BMJ Open; 2017 Aug; 7(8):e016597. PubMed ID: 28851790
[TBL] [Abstract][Full Text] [Related]
8. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
[TBL] [Abstract][Full Text] [Related]
9. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
10. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
Krapp M; Kohl T; Simpson JM; Sharland GK; Katalinic A; Gembruch U
Heart; 2003 Aug; 89(8):913-7. PubMed ID: 12860871
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Neurodevelopmental and Respiratory Outcome after Intrauterine Therapy for Fetal Thoracic Abnormalities.
Witlox RSGM; Lopriore E; Rijken M; Klumper FJCM; Oepkes D; van Klink JMM
Fetal Diagn Ther; 2019; 45(3):162-167. PubMed ID: 29734144
[TBL] [Abstract][Full Text] [Related]
12. Postnatal Outcomes in Infants With a History of Fetal Supraventricular Tachycardia.
Carberry T; Arzu J; Coons D; Husain N; Gotteiner N; Webster G
JACC Clin Electrophysiol; 2022 Sep; 8(9):1145-1151. PubMed ID: 36137720
[TBL] [Abstract][Full Text] [Related]
13. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
Holmes S; Hornberger LK; Jaeggi E; Howley L; Moon-Grady AJ; Uzun O; Kaizer A; Gilicze O; Cuneo BF
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g.
Brumbaugh JE; Hansen NI; Bell EF; Sridhar A; Carlo WA; Hintz SR; Vohr BR; Colaizy TT; Duncan AF; Wyckoff MH; Baack ML; Rysavy MA; DeMauro SB; Stoll BJ; Das A; Higgins RD;
JAMA Pediatr; 2019 May; 173(5):434-445. PubMed ID: 30907941
[TBL] [Abstract][Full Text] [Related]
15. Sotalol in the treatment of fetal dysrhythmias.
Oudijk MA; Michon MM; Kleinman CS; Kapusta L; Stoutenbeek P; Visser GH; Meijboom EJ
Circulation; 2000 Jun; 101(23):2721-6. PubMed ID: 10851210
[TBL] [Abstract][Full Text] [Related]
16. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
Agarwal A; Saha SC; Kaur A; Naganur S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Fetal tachycardia: mechanisms and predictors of hydrops fetalis.
Naheed ZJ; Strasburger JF; Deal BJ; Benson DW; Gidding SS
J Am Coll Cardiol; 1996 Jun; 27(7):1736-40. PubMed ID: 8636562
[TBL] [Abstract][Full Text] [Related]
19. Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.
Hinkle KA; Peyvandi S; Stiver C; Killen SAS; Weng HY; Etheridge SP; Puchalski MD
Pediatr Cardiol; 2017 Oct; 38(7):1317-1323. PubMed ID: 28664446
[TBL] [Abstract][Full Text] [Related]
20. The association of neonatal morbidity with long-term neurological outcome in infants who were growth restricted and preterm at birth: secondary analyses from TRUFFLE (Trial of Randomized Umbilical and Fetal Flow in Europe).
Van Wassenaer-Leemhuis AG; Marlow N; Lees C; Wolf H;
BJOG; 2017 Jun; 124(7):1072-1078. PubMed ID: 28158932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
